33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor DNA (ctDNA) to assess response in patients with anal cancer treated with definitive chemoradiation
    Meeting Abstract

    Alvarez, J.; Cercek, A.; Mohan, N.; Ho, Y. J.; Zinovoy, M.; Reyngold, M.; Yaeger, R.; Hajj, C.; Fanta, C.; Roth O'Brien, D. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer
    Meeting Abstract

    Hong, D. S.; Drilon, A. E.; Tan, D. S. W.; Lin, Jessica J.; Kummar, S.; McDermott, R. S.; Berlin, J.; Italiano, A.; Lassen, U. N.; Leyvraz, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Sustained organ preservation in patients with rectal cancer treated with total neoadjuvant therapy: Long-term results of the OPRA trial
    Meeting Abstract

    Verheij, F. S.; Omer, D. M. R.; Williams, H.; Buckley, J. T.; Lin, S. T.; Qin, L. X.; Thompson, H. M.; Yuval, J. B.; Gollub, M. J.; Wu, A. J. C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors
    Meeting Abstract

    Gu, S.; Dusza, S. W.; Dunkel, I. J.; Drilon, A. E.; Lacouture, M. E.; Markova, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis
    Meeting Abstract

    Dankner, M.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Rajadurai, C. V.; Rousselle, E.; Stein, A.; Bian, D. J.; Tai, P.; Belaiche, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of solid tumors with BRAF fusions
    Meeting Abstract

    Chen, M. F.; Yang, S. R.; Tao, J.; Desilets, A.; Rosen, E.; Gong, Y.; Mullaney, K. A.; Kris, M. G.; Arcila, M. E.; Donoghue, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pan-cancer landscape of FOXA1 alterations: Insights and clinical implications
    Meeting Abstract

    Dee, E. C.; Goglia, A. G.; Khan, A.; Hougen, H. Y.; Swami, N.; Kannikal, J.; McBride, S. M.; Gomez, D. R.; Nguyen, P. L.; Punnen, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results
    Meeting Abstract

    Sherman, E. J.; De La Fuente, M. I.; Yaeger, R.; Tsai, F. Y.C.; Janku, F.; Butowski, N. A.; Allen, C. E.; Ammakkanavar, N. R.; Taylor, J. W.; Samara, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort
    Meeting Abstract

    Repetto, M.; Richards, A. L.; Chen, M. F.; Zhu, Y.; Selenica, P.; Gazzo, A.; Lee, P.; Price, A.; Yang, S. R.; Marra, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save